Top Tweets for #VB111
It is with great excitement that we announce the appointment of Sam Backenroth as our new CFO and the establishment of our U.S. operations in New York. To learn more, please visit: https://t.co/ITr27nTEJW $VBLT #CFO #Leadership #ovariancancer #oncology #OVAL #VB111
We are happy to announce that the independent DSMC of the ongoing OVAL Phase 3 registration-enabling study of VB-111 in #ovariancancer has provided clearance to proceed with no changes to the protocol.
https://t.co/NNhOS4oFLJ $VBLT #OVAL #VB111 #oncology #clinicaltrials #research
Our Founder & CEO Prof. Dror Harats, M.D. will participate in a #fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference. Available on-demand on Mon, Sept 13, 2021 at 7 a.m. ET. https://t.co/MLv0SWI8u8 $VBLT #VB111 #oncology #ovariancancer #OVAL #genetherapy

$VBLT to present at upcoming conferences this month. https://t.co/opy6ePteBr #VB111 #oncology #ovariancancer #biotech #VTSplatform #OVAL #clinicaltrials #InvestorAlerts #firesidechat #Keynote
#VBLTherapeutics Announces New #IND for an #Investigator-Sponsored Phase 2 #Trial of #VB111 in #Recurrent #Glioblastoma https://t.co/2EKNW5m8sP @VBLTherapeutics #healthcare
$VBLT receives milestone payment from NanoCarrier under licensing agreement for #VB111 in Japan. See press release: https://t.co/Nd5ecW71Ll
$VBLT We announce today the initiation and first patient in our Phase 3 OVAL trial, studying lead candidate #VB111 in platinum-resistant #OvarianCancer. To read more, see the press release here: https://t.co/sslHexD8l6

$VBLT We recently announced new data supporting the link between #VB111’s dual mechanism of action and its clinical effect on overall and progression-free survival in recurrent #glioblastoma #GBM patients.
To read more, see the press release here: https://t.co/bYAso9rZH5

$VBLT and NanoCarrier Sign Exclusive Agreement for #VB111 in Japan. Photo: Dr. Ichiro Nakatomi and Prof. Dror Harats https://t.co/Ljepk81dgp

$VBLT New Orphan Drug Designation for #VB111 in Europe for #OvarianCancer, Previously Granted for #Glioblastoma https://t.co/0qVsYK4qMB

$VBLT CEO Dr. Dror Harats talks development of lead candidate #VB111 in phase 3 for #glioblastoma #GBM #BrainCancer https://t.co/BQJGsysTOO
$VBLT CEO Dr. Dror Harats talks development of lead candidate #VB111 in phase 3 for #glioblastoma #GBM #BrainCancer https://t.co/BFH3YZzUkR
$VBLT to Present at the Chardan Gene Therapy Conference Oct. 10 #CorporateOverview #GeneTherapy #VB111 https://t.co/LrMoH1Li7l
$VBLT discusses drug candidate #VB111 on The Bio Report w/@dslevine #glioblastoma #GBM #BrainCancer #ovariancancer https://t.co/8cv1KPqs82
$VBLT discusses drug candidate #VB111 on The Bio Report w/@dslevine #glioblastoma #GBM #BrainCancer #ovariancancer https://t.co/YgCbaySqRG
$VBLT discusses #glioblastoma drug candidate #VB111 on Empowered Patient Podcast w/@KarenJagoda #GBM #BrainCancer https://t.co/LgAdVNUUcw
VBL $VBLT Reports Completion of Enrollment in the Pivotal GLOBE Study with #OfranergeneObadenovec #VB111 https://t.co/2Xf7UbnFv6
Most Popular Users

Elon Musk 
@elonmusk
241.5M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
113.9M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.6M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
89.7M followers

Taylor Swift 
@taylorswift13
83.6M followers

Lady Gaga 
@ladygaga
75.1M followers

Virat Kohli 
@imvkohli
72.9M followers

Kim Kardashian 
@kimkardashian
70.7M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
65.9M followers

Bill Gates 
@billgates
64.9M followers

Selena Gomez 
@selenagomez
62.8M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers







